Studies Show Early Promise Of MannKind's Cancer Immunotherapy Program In Melanoma, Prostate Cancer And Other Solid Malignancies
Links shared publicly online about this topic.
- 1,632total visits
Studies Show Early Promise Of MannKind's Cancer Immunotherapy Program In Melanoma, Prostate Cancer And Other Solid Malignancies
Results of two phase 1 studies demonstrate that the novel, investigational cancer vaccines mkc1106-mt and mkc1106-pp are well-tolerated and show encouraging immune response rates and objective tum
View full resource at medicalnewstoday.com
Tags: Malignancy, Prostate Cancer, Skin Cancer, Melanoma, Prostate, Phase 1 Clinical Trial, Men's Health, Vaccine
Most Recently Shared on November 2, 2009 at 4:59 pm By:
Phase 1 Studies Show Early Promise Of Novel Vaccine for Melanoma, Prostate Cancer And Other Solid Malignancies http://tinyurl.com/yhfpvjo
Also Shared By:
Studies Show Early Promise of MannKind’s Cancer Immunotherapy Program in Melanoma, Prostate Cancer and Other Solid Malignancies
zikkir.com — “Health news” View full resource at zikkir.com
Most Recently Shared on December 19, 2009 at 12:23 pm By:
Studies Show Early Promise of MannKind's Cancer Immunotherapy ... http://bit.ly/6C79Nd
Advertisement
MNT Cancer News
@mnt_cancer
Studies Show Early Promise Of MannKind's Cancer Immunotherapy Program In Melanoma, Prostate Cancer And Other So.. http://bit.ly/2dmPzv
1 year ago...